Deracoxib
Alternative Names: SC 59046Latest Information Update: 02 Aug 2002
At a glance
- Originator Pharmacia Corporation
- Class Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 05 Apr 2000 Monsanto has merged with Pharmacia & Upjohn to form Pharmacia Corporation
- 11 Oct 1999 Preclinical development for Inflammation in USA (PO)
- 11 Oct 1999 Preclinical development for Pain in USA (PO)